Cargando…

Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”

Detalles Bibliográficos
Autores principales: Favresse, Julien, Gruson, Damien, Gheldof, Damien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713812/
https://www.ncbi.nlm.nih.gov/pubmed/31467852
http://dx.doi.org/10.1016/j.ymgmr.2019.100506
_version_ 1783446937105596416
author Favresse, Julien
Gruson, Damien
Gheldof, Damien
author_facet Favresse, Julien
Gruson, Damien
Gheldof, Damien
author_sort Favresse, Julien
collection PubMed
description
format Online
Article
Text
id pubmed-6713812
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-67138122019-08-29 Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders” Favresse, Julien Gruson, Damien Gheldof, Damien Mol Genet Metab Rep Letter to the Editor Elsevier 2019-08-22 /pmc/articles/PMC6713812/ /pubmed/31467852 http://dx.doi.org/10.1016/j.ymgmr.2019.100506 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Letter to the Editor
Favresse, Julien
Gruson, Damien
Gheldof, Damien
Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”
title Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”
title_full Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”
title_fullStr Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”
title_full_unstemmed Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”
title_short Comment on “High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders”
title_sort comment on “high doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: implications for individuals with biotin-responsive inherited metabolic disorders”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713812/
https://www.ncbi.nlm.nih.gov/pubmed/31467852
http://dx.doi.org/10.1016/j.ymgmr.2019.100506
work_keys_str_mv AT favressejulien commentonhighdosesofbiotincaninterferewithimmunoassaysthatusebiotinstreptavidintechnologiesimplicationsforindividualswithbiotinresponsiveinheritedmetabolicdisorders
AT grusondamien commentonhighdosesofbiotincaninterferewithimmunoassaysthatusebiotinstreptavidintechnologiesimplicationsforindividualswithbiotinresponsiveinheritedmetabolicdisorders
AT gheldofdamien commentonhighdosesofbiotincaninterferewithimmunoassaysthatusebiotinstreptavidintechnologiesimplicationsforindividualswithbiotinresponsiveinheritedmetabolicdisorders